182 related articles for article (PubMed ID: 21134112)
1. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
[TBL] [Abstract][Full Text] [Related]
2. To MMP or not to MMP: a role for matrix metalloproteinase 3 in primary sclerosing cholangitis?
Folseraas T; Karlsen TH
Liver Int; 2011 Jul; 31(6):751-4. PubMed ID: 21645205
[No Abstract] [Full Text] [Related]
3. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
4. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
5. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
Alberts R; de Vries EMG; Goode EC; Jiang X; Sampaziotis F; Rombouts K; Böttcher K; Folseraas T; Weismüller TJ; Mason AL; Wang W; Alexander G; Alvaro D; Bergquist A; Björkström NK; Beuers U; Björnsson E; Boberg KM; Bowlus CL; Bragazzi MC; Carbone M; Chazouillères O; Cheung A; Dalekos G; Eaton J; Eksteen B; Ellinghaus D; Färkkilä M; Festen EAM; Floreani A; Franceschet I; Gotthardt DN; Hirschfield GM; Hoek BV; Holm K; Hohenester S; Hov JR; Imhann F; Invernizzi P; Juran BD; Lenzen H; Lieb W; Liu JZ; Marschall HU; Marzioni M; Melum E; Milkiewicz P; Müller T; Pares A; Rupp C; Rust C; Sandford RN; Schramm C; Schreiber S; Schrumpf E; Silverberg MS; Srivastava B; Sterneck M; Teufel A; Vallier L; Verheij J; Vila AV; Vries B; Zachou K; ; Chapman RW; Manns MP; Pinzani M; Rushbrook SM; Lazaridis KN; Franke A; Anderson CA; Karlsen TH; Ponsioen CY; Weersma RK
Gut; 2018 Aug; 67(8):1517-1524. PubMed ID: 28779025
[TBL] [Abstract][Full Text] [Related]
6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
11. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
Janse M; Lamberts LE; Franke L; Raychaudhuri S; Ellinghaus E; Muri Boberg K; Melum E; Folseraas T; Schrumpf E; Bergquist A; Björnsson E; Fu J; Jan Westra H; Groen HJ; Fehrmann RS; Smolonska J; van den Berg LH; Ophoff RA; Porte RJ; Weismüller TJ; Wedemeyer J; Schramm C; Sterneck M; Günther R; Braun F; Vermeire S; Henckaerts L; Wijmenga C; Ponsioen CY; Schreiber S; Karlsen TH; Franke A; Weersma RK
Hepatology; 2011 Jun; 53(6):1977-85. PubMed ID: 21425313
[TBL] [Abstract][Full Text] [Related]
12. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
Satsangi J; Chapman RW; Haldar N; Donaldson P; Mitchell S; Simmons J; Norris S; Marshall SE; Bell JI; Jewell DP; Welsh KI
Gastroenterology; 2001 Jul; 121(1):124-30. PubMed ID: 11438501
[TBL] [Abstract][Full Text] [Related]
13. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
14. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
[TBL] [Abstract][Full Text] [Related]
15. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
16. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
[TBL] [Abstract][Full Text] [Related]
17. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.
Halliday JS; Djordjevic J; Lust M; Culver EL; Braden B; Travis SP; Chapman RW
J Crohns Colitis; 2012 Mar; 6(2):174-81. PubMed ID: 22325171
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association analysis in primary sclerosing cholangitis.
Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
[No Abstract] [Full Text] [Related]
20. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]